[1] |
Garcia Rojo D, Prera Vilaseca A, Sáez Artacho A, et al. Transformation of glandular cystitis into bladder transitional carcinoma with adenocarcinoma areas[J]. Arch Esp Urol, 1997, 50(2): 187-189.
|
[2] |
Thrasher JB, Rajan RR, Perez LM, et al. Cystitis glandularis, transition to adenocarcinoma of the urinary bladder [J]. N C Med J, 1994, 55(11): 562-564.
|
[3] |
陈志强,马胜利,吴天鹏,等. 腺性膀胱炎专题讨论[J]. 临床泌尿外科杂志, 2003, 18(1): 60-62.
|
[4] |
Pacheco II, Macleod RJ. CaSR stimulates secretion of Wnt5a from colonic myofibroblasts to stimulate CDX2 and sucrase-isomaltase using Ror2 on intestinal epithelia[J]. Am J Physiol Gastrointest Liver Physiol, 2008, 295(4): G748-759.
|
[5] |
Shi XY, Bhagwandeen B, Leong AS. CDX2 and villin are useful markers of intestinal metaplasia in the diagnosis of Barrett esophagus [J]. Am J Clin Pathol, 2008, 129(4): 571-577.
|
[6] |
王宁,叶章群,陈志强. 腺性膀胱炎的新认识 [J]. 中华泌尿外科杂志, 2017, 38(3): 235-237.
|
[7] |
Capozza N, Collura G, Nappo S, et al. Cystitis glandularis in children [J]. BJU Int, 2005, 95(3): 411-413.
|
[8] |
Zouari S, Bouassida K, Ahmed KB, et al. Acute urinary retention due to benign prostatic hyperplasia associated with cystitis glandularis in a 22-year-old patient[J]. Pan Afr Med J, 2018, 30: 30.
|
[9] |
王淑玉,李永忠,蔡迪明,等. 腺性膀胱炎的超声表现及其分型探讨 [J]. 西部医学, 2011, 23(7): 1339-1341.
|
[10] |
叶琴,林礼务,薛恩生,等. 彩色多普勒超声对腺性膀胱炎的鉴别诊断价值 [J]. 中华超声影像学杂志, 2010, 19(3): 248-250.
|
[11] |
Huang Y, Liu D, Jiang L, et al. Assessment of cystitis glandularis by transvaginal sonography in women [J]. J Ultrasound Med, 2012, 31(7): 1025-1031.
|
[12] |
刘启平,陈红燕,朱慧,等. 超声造影在膀胱占位性病变诊断中的应用价值 [J]. 肿瘤影像学, 2018, 27(4): 285-288.
|
[13] |
刘启平,王燕,陈红燕. 超微血管显像技术对膀胱占位性病变的诊断价值 [J]. 中国临床医学影像杂志, 2017, 28(12): 869-871+880.
|
[14] |
张虎,马德晶,邹雪雪,等. 腺性膀胱炎的MSCT表现与鉴别诊断 [J]. 医学影像学杂志, 2018, 28(8): 1342-1344+1358.
|
[15] |
崔二峰,唐永强,楚红枝,等. 腺性及囊性膀胱炎的CT表现[J]. 实用放射学杂志, 2018, 34(1): 67-70.
|
[16] |
胡晓林,宋晓明,陈奕杉,等. 腺性膀胱炎的影像学诊断价值比较[J]. 实用放射学杂志, 2017, 33(10): 1636-1638.
|
[17] |
Takizawa N, Matsuzaki T, Yamamoto T, et al. Novel strategy for cystitis glandularis: Oral treatment with cyclooxygenase-2 inhibitor[J]. Int J Urol, 2016, 23(8): 706-708.
|
[18] |
戴青松. 保守治疗低危性腺性膀胱炎30例临床观察[J]. 中国医药指南, 2011, 9(15): 240-241.
|
[19] |
Ouslander JG. Management of overactive bladder[J]. N Engl J Med. 2004, 350(8): 786-799.
|
[20] |
Andersson KE, Wein AJ. Pharmacology of the lower urinary tract: basis for current and future treatments of urinary incontinence[J]. Pharmacol Rev,2004, 56(4): 581-631.
|
[21] |
Morales-Olivas FJ, Estañ L. Solifenacin pharmacology[J]. Arch Esp Urol,2010, 63(1): 43-52.
|
[22] |
何佑仿,李坚,李宏军,等. 女性尿频病因及VE-B电汽化疗法治疗效果观察(附855例报告)[J]. 临床泌尿外科杂志, 2010, 25(11): 855-856.
|
[23] |
岳明宗,单玉喜,高洁,等. 三种经尿道术式治疗腺性膀胱炎的疗效观察 [J/CD]. 中华腔镜泌尿外科杂志(电子版), 2012, 6(2): 42-45.
|
[24] |
王亚荣,唐伟,喻备,等. 单纯TUR与TUR联合THP膀胱灌注治疗腺性膀胱炎的Meta分析 [J]. 重庆医学, 2013, 42(11): 1213-1215.
|
[25] |
龙清志,刘润明. 腺性膀胱炎灌注治疗有效 [J]. 现代泌尿外科杂志, 2012, 17(6): 602-603.
|
[26] |
Ma R, Li XB, Yang G, et al. Feasibility of transurethral electro-resection as sole modality for the treatment of cystitis glandularis[J]. Zhonghua Yi Xue Za Zhi, 2009, 89(36): 2571-2573.
|
[27] |
刘龙强,汪峰,白如玉. 腺性膀胱炎患者术后焦虑抑郁状况分析 [J]. 临床心身疾病杂志, 2017, 23(1): 32-33,54.
|
[28] |
Yuksel OH, Urkmez A, Erdogru T, et al. The role of steroid treatment in intractable cystitis glandularis: A case report and literature review [J]. Can Urol Assoc J, 2015, 9(5-6): E306-309.
|
[29] |
杨旺秋. 腺性膀胱炎TUR术后膀胱内灌注药物的概述 [J]. 国际泌尿系统杂志, 2016, 36(4): 613-615.
|
[30] |
杨林,南勋义. 腺性膀胱炎膀胱灌注治疗无效 [J]. 现代泌尿外科杂志, 2012, 17(6): 604-605.
|
[31] |
罗勇,赵建华,王晨宇. 经尿道膀胱病灶电灼联合膀胱黏膜下注射A型肉毒毒素治疗女性膀胱过度活动症合并腺性膀胱炎的临床疗效观察 [J].国际泌尿系统杂志, 2018, 38(1): 71-75.
|
[32] |
张波,姜兴金,魏伟,等.探讨对腺性膀胱炎使用尿道电切加黏膜下注射丝裂霉素的临床效果 [J]. 中国现代药物应用, 2015, (19): 25-26.
|